Skip Nav Destination
Issue Archive
September 15 1995
In this Issue
Table of Contents
PHOTOGRAPHS
REVIEW
ARTICLES
In vivo biologic effects of PIXY321, a synthetic hybrid protein of recombinant human granulocyte-macrophage colony-stimulating factor and interleukin-3 in cancer patients with normal hematopoiesis: a phase I study
S Vadhan-Raj,HE Broxmeyer,M Andreeff,JC Bandres,ES Buescher,RS Benjamin,NE Papadopoulos,A Burgess,S Patel,C Plager
MULTICENTER STUDY
LETTER
ERRATUM
-
Cover Image
Cover Image
- PDF Icon PDF LinkTable of Contents
Advertisement intended for health care professionals
Email alerts
Advertisement intended for health care professionals